Navigation Links
FDA panel refuses anti-viral cold remedy

An advisory panel voted unanimously against recommending FDA approval for the first antiviral cold medication, dashing company hopes of having the drug on the market in time for this year's cold season. The FDA's Antiviral Drugs Advisory Committee cited safety concerns of the drug pleconaril, which it said were not balanced by the drug's "modest" benefits in treating an illness that is not life-threatening. //

Pleconaril prevents the infection of cells by a group of germs called picornaviruses, which are the most common cause of the common cold. In clinical studies, the drug eased symptoms and cut the duration of colds by about a day. One concern is that pleconaril tablets must be taken within 24 hours of the first symptoms, making the drug's real-life usefulness questionable. Because colds are not serious illnesses, it's unlikely that patients would see a doctor within a day of the first symptoms.

The drug's developer, ViroPharma and marketing partner Aventis Pharmaceuticals, had hoped to have it on the market in the earliest possible under the brand name Picovir. Mark McKinlay, vice president of research and development for Viro Pharma, says the drug isn't dead. The company plans to meet with the FDA in coming weeks to see what steps they need to take to get approval.
'"/>




Page: 1

Related medicine news :

1. Expert panel confident of making AIIMS fully autonomous
2. Increased demand for Bird flu anti-viral drug world wide
3. A remedy to overcome dandruff
4. A remedy to lessen fatigue
5. New remedy for those suffering from Crohns disease
6. Now art comes as a remedy and aid to GPs.
7. Simple remedy to prevent DVT: Eat 6 Tomatoes!
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/30/2017)... , ... March 30, 2017 , ... ... the live audio conference “ Preventing Hospital Readmissions Through Discharge Planning ” with ... at 1:00 pm ET. This conference discusses strategies to prevent readmissions in light ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... squash, announced it has enlisted New York City-based sports and entertainment marketing firm ... and procure sponsorship opportunities for the Professional Squash Association (PSA), which includes first-time ...
(Date:3/29/2017)... ... March 30, 2017 , ... Sublime Naturals and its founder, Kathy Heshelow, ... Spice", it has been used for thousands of years. , "The West has caught ... of " Turmeric: How to Use it For Your Wellness. Overcome Inflammation, Enemy of ...
(Date:3/29/2017)... ... March 29, 2017 , ... Based ... into the challenges employers face in trying to balance both short-term and long-term ... programs? Adding to the growing complexity, companies are finding that the short-term ...
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... ... Device Library for documenting and diagramming network and data center assets and audio-video ... NetZoom subscribers can request new equipment shapes for free and download shapes and ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... TOKYO , March 29, 2017  The ... unique Japanese public-private partnership formed to battle infectious ... investments totaling US$23 million* that could help deliver ... host of debilitating conditions. This ... a Phase 3 clinical trial testing a pediatric ...
(Date:3/29/2017)... leader in accelerated orthodontics, OrthoAccel ® Technologies, Inc. ... Manal Ibrahim , Kenji Ojima , Ivan ... microlecture presenters at the AcceleDent ® booth (#3037) ... Session, April 21-25, 2017. Orthodontists and their staff are ... a.m. On the opening morning of AAO exhibitions, Sat., ...
(Date:3/29/2017)... 2017 Transparency Market Research ... an exhaustive study of the U.S. substance abuse treatment ... are functional in this market at present, making ... companies, such as GlaxoSmithKline Plc., Pfizer Inc., Alkermes ... various marketing strategies to increase their visibility, the ...
Breaking Medicine Technology: